Cell therapy weekly: more indications for Kymriah Member Exclusive NEWS ROUND-UP News & views, Cell therapy Cell therapy weekly: more indications for Kymriah RegMedNet Jan 18, 2018
Kymriah and Yescarta recommended for EU approval News & views, Spotlight on immunotherapy, Cell therapy, CAR-T, UK and Europe Kymriah and Yescarta recommended for EU approval RegMedNet Jul 03, 2018
Cell therapy weekly: Novartis faces production glitch over Kymriah NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy, FDA, UK and Europe, US and Canada, Asia and the rest of the world Cell therapy weekly: Novartis faces production glitch over Kymriah RegMedNet Jul 19, 2018
NICE approves Kymriah for use in adults following commercial agreement with NHS England News & views, Cell therapy, Ethics & policy NICE approves Kymriah for use in adults following commercial agreement with NHS England Freya Leask Feb 01, 2019
Kymriah is first CAR-T therapy to be made available on the NHS Spotlight on immunotherapy, Cell therapy, Ethics & policy, CAR-T Kymriah is first CAR-T therapy to be made available on the NHS RegMedNet Sep 05, 2018
Cell therapy weekly: Kymriah could be available in Japan and stem cells show benefits against multiple sclerosis NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy, Clinical trials, Research, CAR-T, UK and Europe, US and Canada, Asia and the rest of the world Cell therapy weekly: Kymriah could be available in Japan and stem cells show benefits against multiple sclerosis RegMedNet Apr 26, 2018
Cell therapy weekly: Yescarta “is not recommended” for NHS availability Member Exclusive Cell therapy, Ethics & policy, Industry developments, CAR-T, UK and Europe, US and Canada Cell therapy weekly: Yescarta “is not recommended” for NHS availability RegMedNet Aug 30, 2018
Cell therapy weekly: New hurdle in immunotherapy development Member Exclusive NEWS ROUND-UP Spotlight on immunotherapy, Cell therapy, Ethics & policy, Research Cell therapy weekly: New hurdle in immunotherapy development RegMedNet Sep 20, 2018
Cenk Sumen (Thermo Fisher Scientific) on the 'durability' of cell & gene therapies Cenk Sumen (Thermo Fisher Scientific) on the 'durability' of cell & gene therapies Shiraz Ziya Sep 03, 2018
Welcome to our spotlight on immunotherapy! Spotlight on immunotherapy Welcome to our spotlight on immunotherapy! RegMedNet Sep 01, 2018
Shanghai venture will bring advanced cell therapies to China Events Shanghai venture will bring advanced cell therapies to China Freya Leask Sep 28, 2018
NHS England strikes deal for ground-breaking CAR-T therapy in a new European first Member Exclusive News & views, Cell therapy, Ethics & policy NHS England strikes deal for ground-breaking CAR-T therapy in a new European first Jasmine Harris Oct 08, 2018
Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations” Member Exclusive NEWS ROUND-UP Cell therapy, Clinical trials, Ethics & policy Cell therapy weekly: StemGenex receives warning letter from FDA over unapproved cell therapy and facility with “significant violations” RegMedNet Nov 15, 2018
The Cell Manufacturing Imperative Member Exclusive COMMUNITY POST News & views, Spotlight on commercialization and translation, Cell therapy, Manufacturing The Cell Manufacturing Imperative RegMedNet Oct 19, 2017
Cell therapy special: best of 2018 NEWS ROUND-UP News & views, Cell therapy, Gene editing, UK and Europe, US and Canada, Asia and the rest of the world Cell therapy special: best of 2018 RegMedNet Dec 13, 2018
Event preview: CAR-TCR Summit Europe Member Exclusive Events Event preview: CAR-TCR Summit Europe RegMedNet Dec 19, 2017
Cell therapy weekly: CAR influence on T-cells key to improving immunotherapy NEWS ROUND-UP News & views, Spotlight on immunotherapy, Cell therapy, Research, CAR-T, UK and Europe, US and Canada Cell therapy weekly: CAR influence on T-cells key to improving immunotherapy RegMedNet Aug 23, 2018
Raw materials considerations for GMP manufacturing: an interview with Bernd Leistler, CellGenix GmbH Cell therapy, Clinical trials, UK and Europe, US and Canada Raw materials considerations for GMP manufacturing: an interview with Bernd Leistler, CellGenix GmbH RegMedNet May 01, 2018
Optimizing the quality of cell therapy starting materials Cell therapy Optimizing the quality of cell therapy starting materials Hemacare Oct 01, 2018
